GW572016 For Treatment Of Refractory Metastatic Breast Cancer

Clinical trial NCT00062686 · COMPLETED

Trial details

NCT number: NCT00062686
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms, Breast

Start date: 2003-11-01
Primary completion: 2005-02-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.